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Abstract
Background: Small Rho-GTPases are critical mediators of neuronal plasticity and are involved in the pathogenesis
of several psychiatric and neurological disorders. Rac-GTPase forms a multiprotein complex with upstream and
downstream regulators that are essential for the spatiotemporal transmission of Rac signaling. The sigma-1 receptor
(Sig1R) is a ligand-regulated membrane protein chaperone, and multiprotein complex assembly is essential to
sigma-receptor function.
Results: Using immunoprecipitation techniques, we have shown that in mitochondrial membranes Sig1R could directly
interact with Rac1. Besides Rac1, the Sig1R forms complexes with inositol 1,4,5-trisphosphate receptor and Bcl2,
suggesting that mitochondrial associated membranes (MAM) are involved in this macromolecular complex formation.
Assembly of this complex is ligand-specific and depends on the presence of sigma agonist/antagonist, as well as on the
presence of GTP/GDP. Treatment of mitochondrial membranes with (+)-pentazocine leads to the (+)-pentazocine-sensitive
phosphorylation of Bad and the pentazocine-sensitive NADPH-dependent production of ROS.
Conclusion: We suggest that Sig1R through Rac1 signaling induces mild oxidative stress that possibly is involved in the
regulation of neuroplasticity, as well as in the prevention of apoptosis and autophagy.
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Background
The sigma-1 receptor (Sig1R) is a member of a family
of membrane-associated proteins that are found in the
mammalian nervous system and peripheral tissues, in-
cluding the immune and endocrine systems [1]. It has
been suggested that Sig1R may be involved in diseases
of the central nervous system (CNS) including am-
nesia, schizophrenia, depression, Alzheimer’s disease,
and addiction [2,3]. Several CNS drugs show high to
moderate affinities for Sig1R, including antipsychotics,
opioids, antidepressants, antagonists of muscarinic,
D2-dopamine and NMDA receptors, monoamine trans-
porters inhibitors, selective serotonin reuptake inhibi-
tors and monoamine oxidase inhibitors [4,5]. The
Sig1R ligands show anti-amnesic and neuroprotective
effects in a large variety of animal models; block neu-
rodegeneration and regulate neuritogenesis [6].
Sig1R is localized in mitochondria-associated endo-
plasmic reticulum (ER) membranes (MAM), which are
sites for the regulation of mitochondrial bioenergetics
via ER calcium release [1]. This receptor could modu-
late a variety of intracellular signal transduction path-
ways through protein-protein interactions and could be
associated with various proteins, including inositol 1,4,5-
trisphosphate (IP3) receptor (IP3R), IRE, BiP, ankyrin, etc.
in the MAM. In resting condition, Sig1R resides with the
ER-resident chaperone BiP. It has been shown that under
ER stress or via agonist stimulation Sig1R dissociates from
BiP and binds IP3R, enhancing calcium entry into mito-
chondria [1,7]. This calcium spike evokes redox reactions
and ATP productions by regulating Ca2+-dependent
enzymes in the TCA cycle, whereas mitochondrial calcium
overloading leads to apoptosis [8,9]. Furthermore, during
the activation Sig1R translocates to the other cell com-
partments and binds to different membrane proteins,
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including ion channels, kinases, G-protein coupled re-
ceptors (GPCRs), etc. [3,10].
Small Rho GTPases (e.g. Rho, Rac, CDC42) have
been implicated in the neuropathogenesis of several
psychiatric and neurological disorders and are critical
mediators of neuronal growth cone dynamics, den-
dritic spine formation and axonal path finding [11].
Typically, Rac and its downstream effectors promote
neuronal survival while Rho and its downstream effec-
tors are capable of inducing neuronal apoptosis. Rho
family GTPases contain a ∼ 200 amino acid residue Dbl
homology (DH) domain and an adjacent, C-terminal,
120 residue pleckstrin homology (PH) domain. Thus,
these proteins can form multiprotein complexes that
are essential for the transmission of downstream
signaling pathways. The main effector of Rac in the
neurons is p21-activated kinase (PAK). Rac-dependent
activation of PAK promotes survival of neurons
through stimulation of the mitogen-activated protein
kinase (MAPK) and phosphatidyl inositol-3 kinase
(PI3K)/Akt pathways that inhibits the activity of pro-
apoptotic members (e.g., Bad) and enhances the ex-
pression of pro-survival members (e.g., Bcl-xL) of the
Bcl-2 family of proteins [12-14].
A growing body of evidence suggests that reactive
oxygen species (ROS) presented at low or moderate
levels act as secondary messengers to regulate cell
growth, survival, and proliferation [15,16]. Mitochon-
dria are the major intracellular source of ROS. ROS pro-
duced by mitochondria have been shown to play a
significant role in intracellular signaling. Among other
proteins, Bcl-2 is capable of regulating mitochondrial
ROS. In addition to its canonical anti-apoptotic activity,
Bcl-2 has been implicated in mitochondrial ROS regula-
tion by its effect on interaction with the Rac1 [17,18].
Silencing and functional inhibition of Rac1 protein
block the Bcl-2–mediated enhancement of intracellular
superoxide levels. Rac1 is known to be involved in the
assembly and activation of NADPH oxidase complex,
leading to ROS production [19]. It should be noted that
Sig1Rs regulate the neuroplasticity via a potential ER-
mitochondrion-Rac1 pathway, apparently through the
production of the ROS that doesn’t involve Ca2+ signal-
ing [20]. However, it is still not clear how Sig1Rs modu-
late free radicals or reactive oxygen species in the
neuron. We hypothesize that Sig1R could regulate the
production of ROS through ER-mitochondrial Rac1 sys-
tem. This system could promote a mild pro-oxidant
milieu for cellular signaling and induce plastic trans-
formation in neurons. We report here that Rac1 inter-
acts with the Sig1R in a protein complex, containing
IP3R, BiP and Bcl2. This complex in the presence of




Reagents and antibodies were obtained from the follow-
ing sources: anti-OPRS1 (Sig1R) antibody (Abcam, UK),
anti-IP3 receptor antibody (Abcam, UK), Anti-GRP78
(BiP) antibody (Abcam, UK), anti-mitofusin 2 antibody
(Abcam, UK), anti-Rac1 antibody (Santa Cruz, USA),
anti-Bcl 2 antibody (Santa Cruz, USA), GppNHp (Sigma-
Aldrich, USA), GDP (Sigma-Aldrich, USA), pentazocine
(Sigma-Aldrich, USA), haloperidol (Sigma-Aldrich, USA).
Isolation of brain mitochondria
Isolation of cortical non-synaptosomal bovine brain
mitochondria was achieved by using a discontinuous
Percoll gradient [21]. Briefly, brain cortex was removed
and gently homogenized in 10 fold volume of isolation
buffer (5 mM HEPES, 225 mM mannitol, 75 mM
sucrose, 1 mM EGTA, pH 7.5). Homogenate was centri-
fuged at 1,250 × g for 5 minutes. Obtained supernatant
was immediately centrifuged at 21,000 × g for 10 min.
The pellet was resuspended in cold 15% Percoll solution
and layered on the gradient of 23 % and 40 % Percoll so-
lutions. The samples were centrifuged at 25,000 × g for
8 minutes, and lower interphase was collected, washed
twice with isolation buffer and resuspended in isolation
buffer without EGTA. All steps were carried out under
ice-cold conditions.
Mitochondria were tested for oxygen consumption in
the state 3 of respiration in the presence of NAD +-linked
substrates (glutamate +malate). Respiration rate was
400–500 nmol O2/min per mg of protein.
NADPH oxidase assay
NADPH oxidase activity was determined in the incuba-
tion medium contained bovine cortex mitochondria
(60–120 μg of protein), 10 mM phosphate buffer,
130 mM NaCl, 1 mM EGTA, 10 μM flavin adenine
dinucleotide (FAD), 2 mM NaN3, 1 μM (+)-pentazocine
or/and 1 μM haloperidol, 50 μM oxidized cytochrome c,
200 units of superoxide dismutase (SOD) in parallel
samples. Reactions were initiated by the addition of
NADPH to a final concentration of 200 μM. After
30 min, activity was measured as the SOD-inhibitable
increase in absorbance at 550 nm (ΕmM = 21) [22].
Immunoprecipitation and Western blotting
The freshly isolated mitochondrial pellet (0.25 mg for
each sample) was resuspended in isolation buffer
(5 mM HEPES, 225 mM mannitol, 75 mM sucrose) and
mitochondria was incubated either with 1 μM (+)-pent-
azocine or 1 μM haloperidol, or with 10 μM Guanosine
5′-[β,γ-imido]triphosphate (Gpp(NH)p or with 10 μM
GDP at 4°C for 60 min. After incubation mitochondria
was precipitated by centrifugation at 20,000 × g for
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20 min, pellets were resuspended in ice-cold lysis buffer
(20 mM Tris–HCl pH 8.0, 137 mM NaCl, 10% glycerol,
1% Triton X-100, 2 mM EDTA), incubated for 60 min at
4°C. The unsolubilized material was removed by centri-
fugation (60 min at 20,000 × g). The supernatants were
incubated with antibody-bound protein A/G-Agarose
beads overnight at 4°C. After washing, the protein A/G-
Agarose pellets were resuspended in 100 mM glycine,
pH 3.0, for 10 s, and then a pretitrated volume of 1.0 M
Tris, pH 9.5, was added to adjust the pH to 7.4. Protein
complexes in the supernatants (2,500 × g, 10 min) were
then analyzed by Western blotting.
For immunoblotting experiments, 50 μg of protein
was separated by SDS-polyacrylamide gel electrophoresis
and transferred to nitrocellulose sheets. After blocking
with blocking buffer (5% bovine serum albumin, 0.05%
Tween 20 in Tris–HCl-buffered saline), the sheets
were incubated with primary antibodies in the blocking
solution. Labeled bands were visualized using en-
hanced chemiluminescence (Amersham, California, USA)
and analyzed by densitometric scanning. The content
of proteins was quantified by the intensity of the
bands, which is linear to the quantity of samples ap-
plied to the gel.
Bad phosphorylation assay
Bad phosphorylation was determined by PhosphoTracer
BAD(pSer112) + Total BAD ELISA kit (Abcam, UK).
Briefly, the freshly isolated mitochondrial pellet (0.25 mg
for each sample) was resuspended in isolation buffer
(5 mM HEPES, 225 mM mannitol, 75 mM sucrose)
and mitochondria were incubated either with 1 μM
(+)-pentazocine, with 1 μM haloperidol or both ligands
at 4°C for 60 min. After incubation mitochondria were
precipitated by centrifugation at 20,000 × g for 20 min,
pellets were resuspended in ice-cold lysis buffer
(20 mM Tris–HCl pH 8.0, 137 mM NaCl, 10% glycerol,
1% Triton X-100, 2 mM EDTA) and unsolubilized ma-
terial was removed by centrifugation (60 min at 20
000 × g). Mitochondrial extracts were subjected to a
PhosphoTracer assay plate, and total BAD and BAD
(pSer112) were analyzed according to manufacturer’s
protocols.
Protein concentration was determined using a dye-
binding method (Bio-Rad).
Statistical analysis
All experiments were performed in triplicates and re-
peated at least twice. Results are expressed as mean ±
the standard error of the mean (SEM). For statistical
analysis, a t-test was used. A difference between ex-
perimental groups was considered to be significant
when P < 0.05.
Results and discussion
Rac1 interacts with Sig1R through the multiprotein
complex
To investigate the association of Sig1R with Rac1 and
other mitochondrial proteins immunoprecipitation ex-
periments were performed. Mitochondria were incubated
with 10 μM haloperidol (sigma-1 receptor antagonist),
with 10 μM (+)-pentazocine (sigma-1 receptor selective
agonist) or both ligands for 60 min at 4°C. These concen-
trations of drugs were in the clinically relevant range, and
the affinity of both drugs to Sig1R was similar (6.5nM for
haloperidol and 1.7nM, for (+)-pentazocine) [23]. Like
other small G proteins, Rac1 cycles between an inactive,
GDP-bound state and an active, GTP-bound state. To
determine the role of active and inactive state in the for-
mation of the macromolecular complex, mitochondria
were incubated with non-hydrolysable analogs of GTP -
GppNHp or GDP. Mitochondrial extracts were immu-
noprecipitated with agarose-conjugated anti-Sig1R,
anti-IP3R or anti-Bcl-2 antibodies and eluted proteins
were subjected to Western blot analysis (Figure 1).
Western blot of mitochondrial proteins has shown that
Sig1R is immunoprecipitated with the Rac1. The associ-
ation between these proteins is increased in the presence
of (+)-pentazocine (Figure 1A and 1B, lane 5), and the
formation of the immunoprecipitate is decreased in case
of simultaneous treatment of mitochondrial proteins by
(+)-pentazocine and haloperidol (Figure 1A and 1B, lane
6). Interaction between Sig1R and Rac1 is also enhanced
in the presence of GppNHp (Figure 1A and 1B, lane 2),
suggesting that active Rac1 directly or indirectly inter-
acts with Sig1R.
Taking into account that Sig1R forms a complex with
the various proteins in the MAM, we decided to analyze
the binding of Sig1R with the IP3R, BiP and Bcl-2. The
(+)-pentazocine-dependent association of Sig1R with
IP3R was found when immunoprecipitation was per-
formed with Sig1R antibodies and immunoreactivity was
detected by anti-IP3R. (Figure 1Fa, lane 3). Moreover,
vice versa, (+)-pentazocine-dependent dissociation of
Sig1R from BiP was demonstrated when mitochondrial
extracts were immunoprecipitated by anti-Sig1R and im-
munoreactivity was tested by anti-BiP (Figure 1Fb, lane
3). Haloperidol, in both cases, eliminated the effects of
(+)-pentazocine (Figure 1Fa and 1Fb, lane 4), confirming
the observation that sigma-ligands cause the redistribu-
tion of Sig1R between IP3R and BiP [1].
It is interesting that such ligand-specific interactions
between Sig1R and Bcl-2 were not found when immuno-
precipitations were performed by anti-Sig1R (Figure 1Ea
lanes 4–6). However, when mitochondrial extracts were
immunoprecipitated by anti-Bcl2, and protein bands were
detected by anti-Rac1, (+)-pentazocine-dependent increase
of immunoreactivity was found (Figure 1Fc lane 3). These
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data demonstrate that Sig1R is not directly involved in
the formation of the Bcl-2-Rac1 complex. Furthermore,
we have found that Rac1 could be associated with IP3R,
and this association depends on the presence of SigR1-
ligands and guanine nucleotides (Figure 1C and 1D, lanes
1–6). Altogether this suggests that Rac1 specifically binds
to the IP3R and this interaction is regulated by both,
sigma ligands, and guanine nucleotides.
It should be noted that mitofusin-2 (MFN2), one of
the major GTP-binding protein in MAM, was also
immunoprecipitated by anti-Sig1R, however, in this case,
neither sigma ligands nor guanine nucleotides changed
proteins’ association (Figure 1Eb). In addition, we have
found that neither K-Ras nor H-Ras bind to the Sig1R
(data not shown).
Sigma ligands change the activities of Rac1 down-stream
effectors
p21-activated kinases are the best-characterized down-
stream effectors of the Rac1. PAK directly or indirectly,
through other protein kinases (i.e. Raf, Akt) can phos-
phorylate various regulatory proteins, including pro-
apoptotic Bad [24]. Phosphorylation of Bad at S112 and
S136 decreases Bad/Bcl-2 complex formation, which results
in increased cell survival [25]. Thus, one of the targets of
Sig1R-Rac complex in the mitochondria could be the PAK/
Bad pathway. To determine whether sigma ligands change
Bad phosphorylation, mitochondria were incubated with
sigma ligands, and Bad-pSer112 and total Bad were identi-
fied in the mitochondrial extracts. Our results have shown
that (+)-pentazocine decreased the immunoreactivity of
mitochondria against both, Bad(pSer112) and total Bad,
suggesting that the sigma agonist causes dissociation of
Bad from mitochondria. In this case, haloperidol elimi-
nated the effect of pentazocine (Figure 2).
Rac1 is known to be involved in the assembly and acti-
vation of NADPH oxidase. NADPH oxidases (NOX) are
a family of enzyme complexes whose primary function is
to catalyze the transfer of electrons from NADPH to mo-
lecular oxygen, generating superoxide anion and H2O2. It
has been reported that isoforms of NADPH oxidase are
expressed in mitochondria. However, the molecular mech-
anisms underlying the interplay between the NADPH oxi-
dases and the mitochondria remain undefined [26]. To
determine whether sigma ligands change NADPH oxidase
activity, we analyzed the production of ROS in mitochon-
drial suspension. We have found that the production of
ROS was increased in the presence of pentazocine, and
Figure 1 Effect of pentazocine (P), haloperidol (H) and guanine nucleotides on the interaction between the Sig1R, Rac1, and Bcl-2. Mitochondria were
incubated with sigma ligands and guanine nucleotides as described in Material and methods. Mitochondrial extracts were immunoprecipitated with
anti-Sig1R (IP: Sig1R, A, B, E, Fa, Fb), with anti-IP3R (IP: IP3R, C,D) or anti-Bcl2 (IP: Bcl2, Fc) antibodies, the immunoprecipitate was subjected to SDS-PAGE
and transferred. The blots were then probed to Western analysis with antibodies against Rac1(Wb: Rac1, A,C,Fc), Bcl2(Wb:Bcl2, Ea), MFN2(Wb:MFN2, Eb),
IP3R (Wb:IP3R, Fa) and BiP (Wb:BiP, Fb). Results are representative of three independent experiments. (A, C, E, ) Lane 1 – control, no additions; lane 2 – plus
GppNp; lane 3 – plus GDP; lane 4 – plus haloperidol; lane 5- plus (+)-pentazocine; lane 6- plus haloperidol and (+)-pentazocine. (F) Lane 1 – no additions;
lane 2 – plus haloperidol, lane 3 – plus (+)-pentazocine; lane 4 - plus haloperidol and (+)-pentazocine. (B) Quantification of Rac1 blots shown in A; n = 3.
*P< 0.05, compared with control levels. (D) Quantification of Rac1 blots shown in C; n = 3. *P< 0.05, compared with control levels.
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haloperidol eliminated the effect of (+)-pentazocine
(Figure 3).
Rho family GTPases are key players in neuronal devel-
opment, neuronal survival and neurodegeneration [14].
Rac activation typically promotes neuronal survival while
Rho activation often elicits neuronal death [13,27]. In
most cases, Rac-GTPase forms a multiprotein complex
with upstream and downstream regulators that are es-
sential for the spatiotemporal transmission of Rac signal-
ing [11]. Rac1 primarily activates PAK-s increasing
phosphorylation of various regulatory and cytoskeletal
proteins [12,13]. Besides, Rac forms complexes with
p67phox, regulates redox signaling through activation of
NADPH oxidase [19] and could initiate ER-stress [28].
Rac1 may also be found at the mitochondrial membrane
where it interacts with Bcl-2 through the BH3 domain
and initiates mild oxidative stress [17].
Sig1R is neuroprotective in stroke and cerebral ische-
mia, and has been linked to schizophrenia, Alzheimer’s
disease, depression and drug addiction [2,3]. The activity
of Sig1R is regulated by various exogenous ligands, includ-
ing antipsychotic (e.g. haloperidol) and psychotomimetic
(e.g. pentazocine) drugs [29]. The protein-protein inter-
action is essential in sigma-receptor function, and like
Rac1, Sig1Rs are involved in the morphogenesis of neu-
rons [5]. This data suggests that the pathways of regula-
tion of these proteins may cross at various stages of
survival and development of neurons.
Using immunoprecipitation techniques, we have shown
for the first time that Sig1R could directly interact with
Rac1. This interaction is a ligand-specific since the com-
plex between Sig1R and Rac1 is formed only in the pres-
ence of (+)-pentazocine and the complex formation
between these proteins is abrogated by antagonist - halo-
peridol. In addition, our results have shown that the ac-
tive, GTP associated Rac1 is also capable to form a
complex with Sig1R. In our opinion, this complex is as-
sembled on the IP3R, which can interact with a broad
range of proteins in MAM [30]. Our experiments have
shown that (+)-pentazocine reduces the binding of Sig1R
to the BiP and increases its association with IP3R,
whereas haloperidol changes this redistribution. These
data agree with the accepted consideration that after ago-
nist’s stimulation, Sig1Rs dissociate from BiP and act on
IP3Rs, leading to a prolonged Ca2+ signaling into mito-
chondria [1].
Our results have also shown that Rac1 forms multi-
protein complex with Bcl-2 (Figure 1Fc). BH3 domain of
Bcl-2 is necessary for interaction with Rac1, and this
interaction is critical for the pro-oxidant activity of Bcl-2
[17]. It is important that anti-apoptotic Bcl-2 family
members form a macromolecular complex with the
IP3Rs in the ER [31]. The interaction between these pro-
teins sensitizes IP3Rs to low IP3 concentrations leading
to the decline in Ca2+-store and the induction of small
oscillatory Ca2+ signals [32]. As a consequence, cells are
protected against apoptosis. Besides Bcl-2 family mem-
bers, various proteins, involved in the regulation of IP3-
induced Ca2+release from ER, could directly bind to the
IP3R.
To assess the activity of Rac, we have investigated the
effect of sigma ligands on the possible downstream ef-
fector systems. The activity of two best-characterized
target systems of Rac (PAK-protein kinase and NADPH-
oxidase), were analyzed in the mitochondrial fraction.
Figure 2 Effects of (+)-pentazocine and haloperidol on the content
of total Bad and Bad(pSer112) in mitochondrial lysates. Mitochondria
were incubated with haloperidol (H), with (+)-pentazocine (P) or
with both ligands (H + P) as described in Material and methods.
Mitochondrial lysates were subjected to the analyzes of total Bad
and Bad(pSer112). Values in the ELISAs (means ± SD) are
representative of three experiments and are reported as arbitrary
units. Each assay was performed at least in duplicate. *P < 0.05
compared with the control (C).
Figure 3 Effects of pentazocine and haloperidol on the NADPH
oxidase activity. Mitochondria were incubated with haloperidol (H),
with (+)-pentazocine (P) or with both ligands (H + P) and NADPH
oxidase activity determined as described in Material and methods.
Data represented are mean ± SEM of results from four separate
experiments performed in duplicate. *P < 0.05, t test compared with
corresponding control (C).
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PAK could directly phosphorylate various regulatory
proteins, including mitochondrial Bad [24]. Our results
have shown that (+)-pentazocine induces the phosphor-
ylation and subsequent dissociation of Bad from mito-
chondria. Besides, we have found that (+)-pentazocine
increases the NADPH-dependent production of ROS,
which is inhibited by haloperidol. Given that pro-
apoptotic Bad is dissociated from Bcl-2 after phosphoryl-
ation, we conclude that activation of sigma receptor by
an agonist leads to the release of BH3-only protein from
mitochondria (or MAM). This relocation of Bad may be
important for the prevention of apoptosis and autophagy
[33]. The dissociation of Bad from Bcl2 could facilitate
Rac1-Bcl2 interaction and induce mild non-oxidative
ROS formation [18] through mitochondrial NADPH-
oxidase. This mechanism may be involved in the regula-
tion of neuroplasticity by sigma ligands [20].
Thus, we suggest that through IP3R/Sig1R/Bcl-2/Rac1
multiprotein complex, sigma agonists could induce mild
oxidative alterations in mitochondria that may be crucial
for cell homeostasis. However, further studies are clearly
needed to characterize this interaction. Taking into ac-
count the involvement of Rac1 and Sig1R in cancer cell
metabolism, as well as in neurological disorders, under-
standing the molecular basis of their interaction may
have implications for a therapeutic approach, based on
modulation of ER-stress.
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